Speculation and rumors are quite active in the social platforms regarding a upcoming positive move in the stock, like any Medical company these moves can happen when least expected, so have alerts or orders set as the price is now sitting on strong support.
Analyst Average price target $15.50
Analyst Average Recommendation BUY
Trovagene , Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate ( ATP ) competitive inhibitor.
Sign Up for our 100% Free Email Newsletter:
Text Message Alerts ---> text 'PS101' to 67076
(It's FREE, however Msg&Data rates may apply.)